ASO Author Reflections: Rethinking Radiation Associated Angiosarcoma of the Breast-Secondary Malignancies That Require Expert Care for Improved Outcomes

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, Mount Sinai Hospital and Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
² Division of Surgical Oncology, Department of Surgery, Mount Sinai Hospital and Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. rebecca.gladdy@sinaihealth.ca.

Andrea M Covelli et al. Ann Surg Oncol. 2022 Jan.

. 2022 Jan;29(1):533-534.

doi: 10.1245/s10434-021-10633-7. Epub 2021 Aug 17.

¹ Division of Surgical Oncology, Department of Surgery, Mount Sinai Hospital and Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
² Division of Surgical Oncology, Department of Surgery, Mount Sinai Hospital and Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. rebecca.gladdy@sinaihealth.ca.

No abstract available

References

1. Li GZ, Fairweather M, Wang J, Orgill DP, Bertagnolli MM, Raut CP. Cutaneous radiation-associated breast angiosarcoma: radicality of surgery impacts survival. Ann Surg. 2017;265:814–20. - DOI
1. Blay JY, Honore C, Stoeckle E, et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol. 2019;30(7):1143–53. - DOI
1. Blay JY, Soibinet P, Penel N, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28(11):2852–9. - DOI
1. Guram S, Covelli AM, O’Neill A, et al. Multidisciplinary intervention in radiation-associated angiosarcoma of the breast: patterns of recurrence and response to treatment. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10477-1 . - DOI - PubMed
1. Florou V, Rosenberg AE, Wieder E, et al. Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution. J Immunother Cancer. 2019;7(1):213. - DOI